Fosaprepitant PSK

Oncology

Fosaprepitant PSK

Registration certificate:

INN:

Fosaprepitant

Release form:

Lyophilisate for the preparation of a solution for infusion

Therapeutic Area:

Oncology

Pharmacotherapeutic Group:

Antiemetic – Neurokinin Receptor Antagonist

Conditions for dispensing:

On prescription

В упаковке:

Indications for Use:

Fosaprepitant PSK, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic or moderately emetogenic cancer chemotherapy.

This medication is not included in the List of Essential Medicines.